Dosificación de metadona basada en el indice urinario testosterona-creatinina

José Roberto Lozano Ortiz



Palabras clave


Texto completo:

PDF (English)


Cicero, T. J. (1970). An in vivo assay for the analysis of the potency and structure relationships of narcotics: serum testosterone depletion in the male rat. Journal of Pharmacology and Experimental Therapeutics, 202, 670-675.

Cicero, T. J., Bell, R. D., Wiest, W. G., Allison, J. H., Kosiu, K. & Robins, E. (1975). Function of the male sex ongans in heroin and methadone users. New England Journal of Medicine, 292, 882-887.

Crettol, S., Déglon, J. J., Besson, J., Croquette-Krokkar, M., Gothuey, I., Hämmig, R.,… & Besson, J. (2006). ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment. Clinical Pharmacology & Therapeutics, 80,


Dole,V. P. & Nyswander, M. E. (1965). A medical treatment for diacetyl morphine addiction. Journal of the American Medical Association,193, 646-650.

López, M. L., Baño, M. D. & Guillen, J. L. (2000). Algoritmo e interpretación de los niveles plasmáticos de metadona. Trastornos Adictivos, 3, 244-55.

Mendelson, J. H., Mendelson, J. E. & Vernon, D. P. (1974). Plasma testosterone levels in heroin addiction and during methadone maintenance. Journal of Pharmacology and Experimental Therapeutics, 192, 211-217.

Mendelson, J. H., Inturrisi, C. E., Renault, P. & Sinay, E. C. (1976). Effects of acetylmethadol on plasma testosterone. Clinical Pharmacology & Therapeutics, 19,171-374.

Torrens, M., Castillo, C. & Pérez-Solá, V. (1996). Retention in a low threshold methadone maintenance program. Drug and Alcohol Dependence, 41, 55-59.


Enlaces refback

  • No hay ningún enlace refback.